[{"id":"2d1c3ca8-7296-43e4-82a1-3a09a7010bbd","acronym":"C-SMART","url":"https://clinicaltrials.gov/study/NCT04534725","created_at":"2021-01-18T21:42:26.535Z","updated_at":"2024-07-02T16:35:39.087Z","phase":"Phase 3","brief_title":"COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;","source_id_and_acronym":"NCT04534725 - C-SMART","lead_sponsor":"Peter MacCallum Cancer Centre, Australia","biomarkers":" CRP","pipe":"","alterations":" ","tags":["CRP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Xpovio (selinexor) • LENZ (lenzilumab)"],"overall_status":"Completed","enrollment":" Enrollment 441","initiation":"Initiation: 12/17/2020","start_date":" 12/17/2020","primary_txt":" Primary completion: 11/28/2022","primary_completion_date":" 11/28/2022","study_txt":" Completion: 04/19/2023","study_completion_date":" 04/19/2023","last_update_posted":"2023-08-24"}]